Cellular immunity to the Her-2/neu protooncogene

This publication has 127 references indexed in Scilit:

• Class I Major Histocompatibility Complex Anchor Substitutions Alter the Conformation of T Cell Receptor Contacts
  Published by Elsevier ,2001
• Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
  The Journal of Experimental Medicine, 1998
• ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
  The EMBO Journal, 1997
• Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8
  Human Immunology, 1997
• High frequency of altered HLA class I phenotypes in invasive breast carcinomas
  Human Immunology, 1996
• Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevance
  Immunology Today, 1995
• Restricted T cell receptor V-β and J-β usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas
  Cancer Immunology, Immunotherapy, 1993
• Expression of HER‐2/neu in renal‐cell carcinoma. Correlation with histologic subtypes and differentiation
  International Journal of Cancer, 1992
• Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells
  European Journal of Immunology, 1989
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987